Determination of the arterial flow fraction in normal and diseased livers using constrained deconvolution.
There is some evidence that the ratio of the blood flow to the liver through the hepatic artery to the total flow to the liver through the hepatic artery and portal vein (the hepatic arterial flow fraction, AFF) is altered in the presence of cirrhosis. Several methods have been published that seek to provide an index of this ratio. These indices are dependent on factors other than the AFF and cannot provide a true measure of it. The impulse retention function of the liver has two components and these may be derived using a model-driven deconvolution of the arterial tracer concentration curve and the curve of tracer concentration in the liver. The AFF may then be obtained from the relative heights of these two components. Simulation studies show that the AFF calculated using this method is reasonably accurate and a small clinical series shows that it is capable of appropriate clinical classification of patients into cirrhotic and non-cirrhotic groups.
Barber
D C
DC
Department of Medical Physics, Royal Hallamshire Hospital, Sheffield.
Tindale
W B
WB
D003102:Colloids; D006499:Hepatic Artery / Q000502:physiology*; D006801:Humans; D008102:Liver Circulation; D008103:Liver Cirrhosis / Q000000981:diagnostic imaging / Q000503:physiopathology*; D008955:Models, Cardiovascular; D011169:Portal Vein / Q000502:physiology; D011877:Radionuclide Imaging; D012016:Reference Values; D013667:Technetium; D017556:Technetium Compounds; D014001:Tin; D017971:Tin Compounds
D003102:Colloids; D017556:Technetium Compounds; D017971:Tin Compounds; C033493:technetium Tc 99m tin colloid; D013667:Technetium; D014001:Tin